《World Journal of Gastroenterology》2008年19期 加入收藏    获取最新 
 Transplanted bone marrow stromal cells are not cellular origin of hepatocellular carcinomas in a mouse model of carcinogenesis
   AIM:To investigate the malignant potential of hepatic stem cells derived from the bone marrow stromal cells (BMSCs) in a mouse model of chemical hepatocarcino- genesis. METHODS:BMSCs from male BALB/c mice were harvested and cultured, then transplanted into female syngenic BALB/ c mice via portal vein. Hepato-carcinogenesis was induced by 6 mo of treatment with diethylnitrosamine (DEN). Six months later, the liver was removed from each treated mouse and evaluated by immunohistochemistry and fluorescence in situ hybridization (FISH). RESULTS:Twenty-six percent of recipient mice survived and developed multiple hepatocellular carcinomas (HCCs). Immunohistochemically, HCC expressed placental form of glutathione-S-transferase (GST-P) and α-fetoprotein, but did not express cytokeratin 19. Y chromosome positive hepatocytes were detected by fluorescent in situ hybridization (FISH) in the liver of mice treated with DEN after BMSCs transplantation while no such hepatocytes were identified in the liver of mice not treated with DEN. No HCC was positive for the Y chromosome by FISH. CONCLUSION:Hepatic stem cells derived from the bone marrow stromal cells have a low malignant potential in our mouse model of chemical hepatocarcingenesis.
【基金】:The Natural Science Foundation of HainanProvince, No. 805107
【分类号】:R735.7
【DOI】:CNKI:SUN:ZXXY.0.2008-19-011
【正文快照】:
  INTRODUCTION Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world[1]. Hepatitis B or C virus can induce chronic hepatitis and potentially result in liver cirrhosis and HCC, and these viral infections are frequently seen among HCC pa…
 
 推荐 CAJ下载           PDF下载
 CAJViewer7.0阅读器支持所有CNKI文件格式,AdobeReader仅支持PDF格式
 Transplanted bone marrow stromal cells are not cellular origin of hepatocellular carcinomas in a mouse model of carcinogenesis
 Jin-Fang Zheng;Department of Hepatobiliary Surgery;the People’s Hospital of Hainan Province;Haikou 570311;Hainan Province;China Li-Jian Liang;Department of Hepatobiliary Surgery;the First Affiliated Hospital;Sun Yat-Sen University;Guangzhou 510080;Guangdong Province;China
  AIM:To investigate the malignant potential of hepatic stem cells derived from the bone marrow stromal cells (BMSCs) in a mouse model of chemical hepatocarcino- genesis. METHODS:BMSCs from male BALB/c mice were harvested and cultured, then transplanted into female syngenic BALB/ c mice via portal vein. Hepato-carcinogenesis was induced by 6 mo of treatment with diethylnitrosamine (DEN). Six months later, the liver was removed from each treated mouse and evaluated by immunohistochemistry and fluorescence in situ hybridization (FISH). RESULTS:Twenty-six percent of recipient mice survived and developed multiple hepatocellular carcinomas (HCCs). Immunohistochemically, HCC expressed placental form of glutathione-S-transferase (GST-P) and α-fetoprotein, but did not express cytokeratin 19. Y chromosome positive hepatocytes were detected by fluorescent in situ hybridization (FISH) in the liver of mice treated with DEN after BMSCs transplantation while no such hepatocytes were identified in the liver of mice not treated with DEN. No HCC was positive for the Y chromosome by FISH. CONCLUSION:Hepatic stem cells derived from the bone marrow stromal cells have a low malignant potential in our mouse model of chemical hepatocarcingenesis.
【Keyword】:Bone marrow stromal cell;Stem cell;Hepatocarcinogenesis;Animal study
 【参考文献】 共(8)篇 
 西文参考文献找到 8 条
 
1Gournay J, Auvigne I, Pichard V, Ligeza C, Bralet MP, Ferry N; In vivo cell lineage analysis during chemical hepatocarcinogenesis in rats using retroviral-mediated gene transfer: evidence for dedifferentiation of mature hepatocytes. [M];Lab Invest; 2002年
2Dumble ML, Croager EJ, Yeoh GC, Quail EA; Generation and characterization of p53 null transformed hepatic progenitor cells: oval cells give rise to hepatocellular carcinoma. [M];Carcinogenesis; 2002年
3Sakata K, Hara A, Hirose Y, Yamada Y, Kuno T, Katayama M, Yoshida K, Zheng Q, Murakami A, Ohigashi H, Ikemoto K, Koshimizu K, Tanaka T, Mori H; Dietary supplementation of the citrus antioxidantauraptene inhibits N,N-diethylnitrosamine- induced rat hepatocarcinogenesis. [M];Oncology; 2004年
4Perz JF,Armstrong GL, Farrington LA, Hutin YJ, Bell BP; The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide [M];J Hepatol; 2006年
5Wakasa T, Wakasa K, Shutou T, Hai S, Kubo S, Hirohashi K, Umeshita K, Monden M; A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma. [M];Hepatogastroenterology; 2007年
6Dumble ML, Knight B, Quail EA, Yeoh GC; Hepatoblast- like cells populate the adult p53 knockout mouse liver: evidencefor a hyperproliferative maturation-arrested stem cell compartment. [M];Cell Growth Differ; 2001年
7Kagawa M, Sano T, Ishibashi N, Hashimoto M, Okuno M, Moriwaki H, Suzuki R, Kohno H, Tanaka T; An acyclic retinoid, NIK-333, inhibits N-diethylnitrosamine-induced rat hepatocarcinogenesis through suppression of TGF-alpha expression and cell proliferation. [M];Carcinogenesis; 2004年
8Lee JS, ,Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi DF, Mikaelyan A, Roberts LR, Demetris AJ, Sun Z, Nevens F, Roskams T, Thorgeirsson SS; A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells [M];Nat Med; 2006年